Javier “Jave” Castillo, R.Ph, Vice President, CSO Strategy, IQVIA
Advertisement
Articles by Javier “Jave” Castillo, R.Ph, Vice President, CSO Strategy, IQVIA
Brand Insights - Thought Leadership | Paid Program
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
2
FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy
3
Median Drug Launch Prices Hit $257,000 as Access Barriers Persist, ICER and West Health Report Finds
4
Pharmaceutical Executive Daily: FDA Approves Hibsago
5